Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

2.79
Delayed Data
As of Feb 22
 -0.17 / -5.74%
Today’s Change
2.42
Today|||52-Week Range
6.50
-3.12%
Year-to-Date

Today’s Trading

Previous close2.96
Today’s open2.93
Day’s range2.79 - 2.95
Volume80,649
Average volume (3 months)193,944
Market cap$61.4M
Dividend yield--
Data as of 02/22/2017

Growth & Valuation

Earnings growth (last year)-3.00%
Earnings growth (this year)+5.18%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1,310.90
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.04-0.94%
NBYNovaBay Pharmaceutic...0.000.00%
CURRCure Pharmaceutical ...-0.40-15.38%
TCONTRACON Pharmaceutica...-0.15-3.90%
Data as of 10:55am ET, 02/22/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$184.0K
Annual profit (last year)-$62.8M
Net profit margin-34,151.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs